Recommendation from Pharmaceuticals Sector

Recommendation from Pharmaceuticals Sector

This column gives you scrip chosen by the research team during the fortnight that is fundamentally strong and expected to give good capital appreciation over a time period of 1 year. 


Rate this article:
5.0

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary25-Apr, 2024

Penny Stocks25-Apr, 2024

Mindshare25-Apr, 2024

Penny Stocks25-Apr, 2024

Multibaggers25-Apr, 2024

Knowledge

Fundamental21-Apr, 2024

General21-Apr, 2024

Technical19-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR